Roche Acquires Billionaire-Backed Weight-Drug Maker for $3.1 Billion in Major Pharma Deal
(Bloomberg) — In a bid to break into the burgeoning weight-loss market, Roche Holding AG has announced its acquisition of Carmot Therapeutics Inc., a pioneer in the development of cutting-edge weight-loss treatments. The deal, valued at up to $3.1 billion, has the potential to position the Swiss pharmaceutical giant as a formidable competitor to European …